CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Ashwagandha +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06264986
NCT06264986N/ACompleted

The Effects of Ashwagandha (Withania Somnifera) Supplementation on Exercise Performance in Female Footballers

Blanca Roman-Viñas, MD·interventional·Posted Feb 20, 2024·Updated Jan 9, 2025

In Brief

A clinical study evaluating Ashwagandha and Placebo for Muscle Strength. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to evaluate the effects of short-term root extract ashwagandha supplementation on exercise performance in female footballers. The main question it aims to answer are: Will short-term supplementation of root extract ashwagandha improve muscle strength markers in female footballers? Will short-term supplementation of root extract ashwagandha improve perception of recovery following high-intensity exercise in female footballers? Participants will either supplement 600mg (5% withanolides) root extract ashwagandha or placebo once a day for 28 days. There will be three data points: baseline, 14 days and 28 days. Researchers will compare values of intervention against placebo to see if there is an effect on muscle strength or perception of recovery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMuscle Strength
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 20, 2024
Enrollment StartJan 13, 2024
Primary CompletionFeb 21, 2024
Study CompletionApr 27, 2024
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 2.4 years ago

Interventions

Ashwagandhadietary

The intervention will be 600mg of KSM-66, a branded supplement derived from the root extract of the herb ashwagandha, with a consistent rate of 5% withanolides for 28 days. It is the most clinically studied extract of the herb and is the only type of ashwagandha to receive third party testing certification (Informed Sport, Informed Ingredient, Banned Substances Control Group, Clean Label Project). The laboratory where the product is made, Ixoreal Biomed, has received Current Good Laboratory Practices (cGLP), quality controlled and tested against heavy metals and pesticides.

Placeboother

600mg chickpea flour in a hydroxypropyl methylcellulose capsule, once a day for 28 days